Advertisement
Canada markets closed
  • S&P/TSX

    22,011.72
    +139.76 (+0.64%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CAD/USD

    0.7319
    +0.0018 (+0.25%)
     
  • CRUDE OIL

    83.34
    -0.02 (-0.02%)
     
  • Bitcoin CAD

    90,711.77
    -456.85 (-0.50%)
     
  • CMC Crypto 200

    1,429.68
    +14.92 (+1.05%)
     
  • GOLD FUTURES

    2,335.60
    -6.50 (-0.28%)
     
  • RUSSELL 2000

    2,002.64
    +35.17 (+1.79%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • NASDAQ futures

    17,673.00
    +66.25 (+0.38%)
     
  • VOLATILITY

    15.69
    -1.25 (-7.38%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • CAD/EUR

    0.6836
    -0.0014 (-0.20%)
     

Theratechnologies to Announce Financial Results for the Third Quarter of 2015

MONTREAL, QUEBEC--(Marketwired - Sept. 21, 2015) - Theratechnologies Inc. (TH.TO) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, 2015, on Thursday, October 1st, 2015, before markets open.

A conference call will be held the same day at 8:30 a.m. (ET) to discuss the results. The call will be hosted by Luc Tanguay, President and Chief Executive Officer. The conference call will be open to questions from financial analysts. Media and other interested individuals are invited to participate in the call on a "listen-only" mode.

The conference call can be accessed by dialling 1-877-223-4471 (North America) or 1-647-788- 4922 (International). The conference call will also be accessible via webcast at http://www.gowebcasting.com/6854. Audio replay of the conference call will be available until October 23, 2015, by dialling 1-800-585-8367 (North America) or 1-416-621-4642 (International) and by entering the playback code 16666146.

About Theratechnologies

Theratechnologies (TH.TO) is a specialty pharmaceutical company addressing unmet medical needs in metabolic disorders to promote healthy ageing and improved quality of life. Further information about Theratechnologies is available on its website at www.theratech.com and on SEDAR at www.sedar.com.